TCL Archive NCI To Proceed With Its Training Program Without Waiting For Implementation of Research Service Act September 20, 1974
TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive HHS lawyer tells of pressure to allow former NCI Director Richard Klausner to receive $40,000 prize. May 21, 2004
TCL Archive FDA Lacks Resources To Deal With Onslaught Of New Cancer Drugs, Friedman Tells Agency August 14, 1992
